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ABSTRACT Okadaic acid (OA)-induced germ-
inal vesicle breakdown (GVBD) and localization of
protein phosphatase-1 (PP1) in oocyte nuclei are
suggestive of PP1’s role in regulating oocyte GVBD.
To explore this possibility, we microinjected protein
phosphatase (PP) inhibitors OA, anti-PP1 antibody
(anti-PP1), PP1 inhibitor I2, and anti-PP2A antibody
(anti-PP2A) into nuclei of roscovitine (ROSC)-arrested
mouse oocytes. Oocytes were also injected with recom-
binant PP1 in the absence of ROSC. Oocytes were
assessed for GVBD andmetaphase II (MII) development
at 2 and 18 hr post-injection. Data were analyzed using
Cochran-Mantel-Haenszel Statistics adjusted for time.
Microinjection of OA significantly enhanced GVBD in
comparison to controls at 2 and 18 hr (P<0.01), yet
had no effect on MII development. Similarly, micro-
injection of anti-PP1 resulted in significantly higher
levels of GVBD compared to controls at 2 and 18 hr
(P<0.01). Interestingly, anti-PP1 microinjection also
tended to enhance MII development at 18 hr in com-
parison to controls (P<0.09). Microinjection of I2,
anti-PP2A, and PP1 had no effect on GVBD or MII
development. If reduction of PP1 activity was important
for GVBD, one would anticipate an endogenous means
of regulating PP1 activity at this developmental stage. In
somatic cells, phosphorylation of PP1 at Thr320 causes
PP1 inactivation. Germinal vesicle-intact oocytes did
not contain phosphorylated PP1, as determined using a
specific Thr320-Phospho-PP1 antibody, Western blot
analysis, and confocal immunocytochemistry. At or
around the time of GVBD, oocyte PP1 became phos-
phorylated at Thr320, which remained phosphorylated
through MII development. These data indicate that
inhibition of intra-nuclear PP1, through specific anti-
body neutralization, mimics OA-stimulated GVBD, pro-
viding the first direct evidence that nuclear PP1 is
involved in regulation of oocyte nuclearmembrane integ-
rity. In addition, phosphorylation of PP1 occurs at/or
around GVBD indicating that inactivation of PP1 is an
important intracellular event in regulation of nuclear
envelope dissolution at GVBD. Mol. Reprod. Dev. 65:
96–103, 2003.  2003 Wiley-Liss, Inc.
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INTRODUCTION
Elucidating regulatory mechanisms involved in
oocyte meiosis is imperative to fully understand this
complex process and allow for optimization of in vitro
maturation systems. Mouse oocytes spontaneously
resume meiosis once removed from their follicular
environment (Pincus andEnzmann, 1935). This process
involves the oocyte leaving a state of quiescence at
prophase of meiosis I, undergoing dissolution of the
nuclear envelope (NE) in a process known as germinal
vesicle breakdown (GVBD), and finally re-arresting at
metaphase ofmeiosis II until fertilization. These oocytes
are referred to as meiotically competent. Release of the
oocyte from its quiescent state, aswell as other processes
in cell cycle progression, is regulated by intracellular
phosphorylation/dephosphorylation events. Numerous
kinases have been investigated and implicated in oocyte
meiotic regulation, while the role of specific protein
phosphatases (PP) has largely been overlooked. Two
specific kinases, mitogen-activated protein kinase
(MAPK) and maturation promoting factor (MPF) have
been studied extensively (reviewed by Abrieu et al.,
2001). Maturation promoting factor consists of two
subunits, cyclin B and p34cdc2 kinase (Labbe et al.,
1989). Through a series of phosphorylation events,MPF
activation leads to GVBD and completion of meiosis I
(Maller, 1993). In meiotically competent oocytes, MPF’s
p34cdc2 kinase and cyclin B are predominantly localized
within nuclei (Mitra and Schultz, 1996). Inhibition of
MPF with the pharmacological inhibitor roscovitine
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(ROSC) can blockmouse oocyteGVBD (Mermillod et al.,
2000).
Serine threonine PPs, which remove phosphate from
phosphoproteins, thus antagonizing protein kinases,
are also implicated in regulating meiosis (Rime et al.,
1990; Gavin et al., 1991; Schwartz and Schultz, 1991;
Smith et al., 1998a,b). Of the four types of serine/
threonine PPs that exist (PP1, PP2A, PP2B, and PP2C;
Ingebritsen and Cohen, 1983; Cohen, 1989), two specific
PP’s, protein phosphatase-1 (PP1) and PP2A, have been
observed inXenopus (Rime et al., 1990), starfish (Picard
et al., 1989), and mouse (Smith et al., 1998a) oocytes.
Immunocytochemical studies have shown PP1 to be
localized to the nucleus of mouse and monkey oocytes
following acquisition ofmeiotic competence, while PP2A
is predominantly cytoplasmic (Smith et al., 1998a,b).
An important discovery in phophatase research was
identification of the cell-permeable inhibitor of PP1 and
PP2A, okadaic acid (OA; Bialojan et al., 1988). Oocyte
microinjection or culture with OA causes premature
GVBD in oocytes of several species including starfish
(Picard et al., 1989), Xenopus (Rime et al., 1990; Goris
et al., 1989), monkey (Smith et al., 1998b), and mouse
(Alexander et al., 1991). Constant exposure of oocytes to
OA results in severe cytoplasmic and spindle aberra-
tions and blocks progression to MII (Rime et al., 1990;
Gavin et al., 1991; Lu et al., 2002), while transient
exposure to induce GVBD is compatible with normal
oocyte development and fertilization (Smith et al.,
1998b). Collectively, this would indicate that inhibition
of a PP can stimulate GVBD, but some PP activity is
necessary for meiotic progression to MII. However, the
specific roles of PP1 and PP2A in oocytes remain
unknown.
Meiotic resumption involves oocyte NE dissolution at
GVBD. The NE consists of a network of filament-type
proteins known as nuclear lamins (Stuurman et al.,
1998). The three major constituents of the nuclear
lamina are A, B, and C type lamins (Eggart et al., 1993).
Nuclear lamina have been characterized in amphibian
and vertebrate oocytes (Krohne et al., 1981; Schatten
et al., 1985;Maul et al., 1987) andmouse oocytes contain
all three lamins (Schatten et al., 1985;Maul et al., 1987;
Houliston et al., 1988). Nuclear envelope integrity is
controlled through phosphorylation and dephosphory-
lation of nuclear lamins. Hypo-phosphorylation of
nuclear lamins maintains NE integrity, while hyper-
phosphorylation of lamins results in NE disassembly
(Stuurman et al., 1998). In somatic cells, PP1 is in-
volved in lamin-B dephosphorylation (Thompson
et al., 1997), while protein kinase C (PKC; Goss et al.,
1994; Thompson and Fields, 1996) and possibly
p34cdc2kinase are responsible for phosphorylation of
lamin-B (Nikolakaki et al., 1997). A complex containing
p34cdc2 kinase and cyclin B, similar to MPF, is im-
plicated in disassembly of clam oocyte NE (Dessev et al.,
1991). Thus, inmitotic cells, it appears thatNE integrity
is determined through protein kinase and PP inter-
actions and balance of these enzymes in regulating
the phosphorylation of NE phosphoproteins. However,
components regulating NE integrity during meiosis
remain to be identified.
Intracellular mechanisms regulating PP1 and PP2A
are numerous and diverse. In cell-free extracts PP1, but
not PP2A, is sensitive to nanomolar concentrations of
cytoplasmic inhibitors I1and I2 (IngebritsenandCohen,
1983). Inactivation of PP1 by I1 involves I1 phosphory-
lation by protein kinase-A (Endo et al., 1996), whereas
I2 does not require phosphorylation. In addition, it has
been demonstrated that cdc2 kinase phosphorylation of
PP1 on Thr320 causes PP1 inactivation (Dohadwala
et al., 1994; Kwon et al., 1997). To date, the regulation of
PP1 in the oocyte has not been determined.
The objectives of this study where to determine which
OA sensitive PP, PP1, and/or PP2A, is involved in
regulating NE dissolution during oocyte GVBD, and to
elucidate mechanisms involved in regulating oocyte PP
activity at/or around the time of GVBD.
MATERIALS AND METHODS
Mouse Stimulation and Oocyte Collection
Female CF1 mice (Harlan; Indianapolis, IN) 19–
23 days old were injected with 10 IU eCG (Sigma;
St. Louis, MO). Fully-grown GVBD-competent oocytes
were collected 42–44 hr post-eCG injection. These GVI
oocytes were isolated by manual rupturing of antral
ovarian follicles in Hepes-buffered Human Tubal Fluid
medium (Quinn et al., 1985; Irvine Scientific, Santa
Ana, CA) supplemented with 0.3% w/v polyvinylpyrro-
lidone (Sigma; HTFHþPVP). In some experiments,
oocytes were cultured in Human Tubal Fluid medium
(HTF; Irvine Scientific) supplementedwith PVP for 2, 7,
and 16 hr followingGV-intact oocyte collection to isolate
GVBD, MI, and MII oocytes, respectively.
Roscovitine Dose Titration
Oocyteswere denuded through repeatedmouth pipet-
ting with hand-pulled pipettes of decreasing diameters
(200 thru 90 mm) and placed into organ culturewells in
groups of 20–30/900 ml of HTF supplementedwith 3mg/
ml fraction V BSA (FisherBiotech; Fair Lawn, NJ) and
0, 6.25, 12.5, 25, or 50 mM ROSC (BioMol, Plymouth
Meeting, PA). Oocytes were cultured in 5%CO2 in air at
378C and assessed for stage of nuclear maturation at
400 on an inverted microscope with Hoffman optics
after 2, 4, 6, and 18 hr of culture. This experiment was
performed to determinea dose ofROSC thatwould allow
40–60% GVBD during 16 hr-culture. This tempering
of spontaneous GVBD was essential to determine if
inhibition of PP1 and/or PP2A stimulates mouse oocyte
GVBD.
Oocyte Germinal Vesicle Microinjection
Oocytes were collected as described above and placed
into HTFHþPVP medium supplemented with 50 mM
ROSC formicroinjection. Oocytes weremicroinjected on
aNikon invertedmicroscopewithHoffman optics equip-
ped with Narishige micromanipulators and a Tritech
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microinjector (Mager Scientific, Dexter, MI). Oocyte GV
were injected at 400 magnification with 8 rl of 1 mM
OA(Calbiochem;SanDiego,CA),1mMI2(BioMol), 1mM
anti-PP1 antibody (UpstateBiotechnology, LakePlacid)
and 1mManti-PP2A antibody (Upstate Biotechnology).
The microinjected volumes were confirmed as pre-
viously described (Corson and Fein, 1983). Controls for
each chemical treatment included buffer injection and
no injection.
Microinjected and control oocytes were placed into
organ culture wells containing 900 ml HTF medium
supplemented with 0.3% BSA and 50 mM ROSC and
cultured as described above. Oocytes were assessed for
stage of nuclearmaturation at 2 and 18 hr post-injection
at 400 on an inverted microscope. Recombinant PP1
(1mM; Upstate) was also injected into oocyte nuclei in
the absence of ROSC and cultured to assess effects on
nuclear maturation at 2 and 18 hr post-injection.
Electrophoresis and Western Blot Analysis
Two hundred frozen cumulus cell-free fully grown
GV-intact, GVBD, MI, or MII oocytes were thawed in
prewarmed 2SDS–PAGE sample loading buffer
(80 mM Tris-HCl [pH¼6.8], 20% glycerol, 4% SDS, 4%
b-mercaptoethanol, 0.04% bromophenol blue), vortexed
and placed on ice for 15min. Following sonication on ice,
samples were denatured at 908C for 10 min and placed
on ice for 5 min. Samples were stored at 208C until
electrophoresis was performed.
Total protein from two hundred mouse oocytes was
loaded in each lane and separated by one-dimensional
SDS–PAGE. Resolving gels were cast using 12% acryl-
amide; stacking gels contained 5% acrylamide. Ap-
proximately 5 mg of cdc2 phosphorylated PP1 HeLa cell
lysate (Cell Signaling Technology Inc., Beverly, MA)
was used as a positive control for recognizing PP1 and
Phospho-PP1.Gelswere equilibrated and transferred to
Hybond-P PVDF transfer membrane (Amersham Life
Science, Little Chalfont Buckinghamshire, England)
by Semi-Dry Electrophoretic Transfer (Bio-Rad Labora-
tories, Hercules, CA). Blots were blocked in 5% nonfat
milk in TBST at room temperature for 1 hr and
incubated with anti-phospho-PP1 (Thr320; diluted
1:1000, Cell Signaling Technology Inc.) antibody in
TBST plus 5% nonfat milk overnight at 48C with
agitation. After complete washing in TBST, blots were
incubated with anti-rabbit horseradish peroxidase-
conjugated IgG (diluted 1:10,000) at room temperature
for 1 hr, washed in TBST, and developed with ECL Plus
reagents (Amersham Life Sciences, Buckinghamshire,
UK).
To investigate expression of PP1, blots were stripped
for 30 min at 508C water bath with agitation in a
stripping buffer (62.5 mM Tris-HCl [pH 6.7], 100 mM
b-mercaptoethanol, and 2% SDS). Completely stripped
blots were blocked in 5% nonfat milk in TBST for 1 hr at
room temperature, then incubated with anti-PP1 anti-
body (diluted 1:1,000, a gift from Dr. Angus Nairn,
Rockefeller University) overnight at 48C with agitation
and processed further as described above.
Immunocytochemistry and
Confocal Microscope Analysis
In order to identify the localization on PP1 and
phospho-PP1 during meiotic resumption, GV-intact
and GVBD oocytes were collected, attached to poly-
lysine coated coverslips, and fixed in 2% (wt/vol) para-
formaldehyde with 0.04% (v/v) Triton X-100. Oocytes
were thenblocked overnightwith0.3% (w/v)BSA inPBS
at 48C, and incubated with anti-PP1 antibody at a 1:200
dilution or a polyclonal anti-phospho-PP1a antibody at a
1:50 dilution for 1 hr at 378C. After washing with 0.3%
BSAþ0.1% (v/v) Tween-20 in PBS, oocytes were incu-
bated in the same wash buffer for 90 min at 378C.
Samples were then reacted with anti-rabbit Alexa 488-
conjugated secondary antibody (Molecular Probes,
Eugene, OR) at a 1:1,000 dilution for 1 hr at 378C.
Following washing, slides were incubated with 5 mg/ml
propidium iodide (PI) in PBS containing 0.1% (w/v) BSA
for 20 min at 378C. Coverslips were then mounted on
glass slides with 90% glycerol in PBS for fluorescence
microscopic visualization with a Bio-Rad MRC-600
confocal scanning laser microscope.
Statistical Analysis
In ROSC dose–response experiments, data were
collected over six replicates and analyzed using Fisher’s
Exact test.Microinjection datawere collected over three
to four replicates for each treatment and GVBD data
were analyzed using Cochran-Mantel-Haenszel Statis-
tics adjusted for time. Metaphase II development data
were analyzed using Mantel-Haenszel Chi-Square.
Differences were considered significant at P<0.05.
RESULTS
In initial experimentation, we determined a dose of
ROSC that would partially inhibit GVBD in mouse
oocytes. This was important for subsequent microinjec-
tion experiments examining effects of various PP inhi-
bitors on GVBD. Under normal circumstances, a very
highpercentage ofmouse oocytes spontaneously resume
meiosis and undergo GVBD. To determine if PP inhi-
bition stimulated GVBD, a tempering of spontaneous
GVBD was necessary. The goal was to establish a
minimal dose of ROSC that would partially inhibit the
population’s ability to undergo GVBDwithout complete
inhibition. Culturing oocytes in 6.25 mM ROSC did not
significantly alter GVBD compared to controls at any
time point (Fig. 1). Culture of mouse oocytes in presence
of 12.5, 25, and 50 mMroscovitine significantly inhibited
GVBD compared to controls at all time points examin-
ed (P<0.05; Fig. 1). The presence of 12.5 mM ROSC did
not alter GVBD compared to oocytes cultured in the
presence of 6.25 mM ROSC at any time point examined
(Fig. 1). Culture in the presence of 25 mM significantly
prevented GVBDmore than culture in 6.25 and 12.5 mM
ROSC at all time points (P< 0.05; Fig. 1). Addition of
50 mM ROSC to oocyte culture media significantly de-
creased GVBD compared to all other treatments at
all time points examined (P<0.05; Fig. 1). The 50-mM
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dose of ROSC permitted between 30 and 50% of
oocytes to spontaneously resume meiosis within 2 to
16 hr of culture, respectively. Based on these data, we
chose a dose of 50 mM for subsequent microinjection
experiments.
Microinjection of OA, an inhibitor of both PP1 and
PP2A, into GV of ROSC-arrested oocytes significantly
enhancedGVBD in comparison to controls at 2 and18hr
post injection. (2 hr: OA-73%, buffer-41%, no injection-
40%; 18 hr: OA-85%, buffer-49%, no injection-61%;
P<0.01; Fig. 2a). Even though OA GV-microinjection
of ROSC-arrested oocytes stimulated GVBD, it had no
significant effect on MII development at 18 hr (OA-
n¼39, 38%; buffer-n¼39, 38%; no injection-n¼ 75,
40%).
Similar to OA injection, anti-PP1 antibody micro-
injection into GV of ROSC arrested ooyctes significantly
increasedGVBDat 2 and 18 hr post-injection (2 hr: anti-
PP1-59%, buffer-40%,no injection-35%; 18hr: anti-PP1-
71%, buffer-56%, no injection-50%; P<0.01; Fig. 2b).
Interestingly, microinjection of anti-PP1 antibody into
oocytes tended to enhance MII development at 18 hr
(anti-PP1-51%, buffer-32%, no injection-32%; P<0.09).
Microinjection of the PP1 cytoplasmic inhibitor, I2,
had no effect on GVBD compared to controls (2 hr: I2-
n¼77, 54%; buffer-n¼42, 50%; no injection-n¼ 59,
53%; 18 hr: I2-79%, buffer-69%, no injection-66%;
Fig. 3). Similarly, I2 microinjection into ROSC arrested
oocytes had no effect on MII development (I2-33%,
buffer-36%, no injection-36%).
To verify PP1 was indeed the PP responsible for
maintaining NE integrity, anti-PP2A was also micro-
injected into ROSC-arrested oocytes. Germinal vesicle-
microinjection of anti-PP2A into ROSC arrested oocytes
hadno effect onGVBDat2 or 18hr (2hr: anti-PP2A-58%
buffer-57%, no injection-59%; 18 hr: anti-PP2A-76%,
buffer-74%, no injection-73%; Fig. 3) or MII develop-
ment at 18 hr post-injection (anti-PP2A-36%, buffer-
42%, no injection-42%).
Finally, we wished to determine if microinjection of
purified recombinant PP1 into nonROSC-arrested
oocyte GV could prevent GVBD. Microinjection of PP1
had no effect on GVBD at 2 hr (PP1-n¼ 32, 76%; buffer-
n¼ 35, 80%; no injection-n¼30, 77%) or MII develop-
ment at 18 hr post-injection (PP1-59%, buffer-61%, no
injection-60%).
Due to the lack of effect on GVBD of microinjection of
recombinant PP1, we decided to perform Western blot
analysis, followed by immunocytochemistry and con-
focal image analysis to determine whether the phos-
phorylated state, and therefore, the activity of PP1,
varies during oocyte maturation. Western blot analysis
showed the presence of PP1 in GV-intact, GVBD, MI,
and MII stage oocytes. However, phosphorylated PP1
was only present following GVBD (Fig. 4). Confocal
image analysis verified the presence of PP1 in the GV-
intact mouse oocyte, while phosphorylated PP1 was
Fig. 1. Roscovitine (ROSC) dose titration and effects on germinal
vesicle breakdownofmouse oocytes cultured for 2, 4, 6, and 18hr.Doses
of ROSC and number of oocytes evaluated in each treatment were 0
(control; n¼139), 6.25 (n¼142), 12.5 (n¼127), 25 (n¼ 141), and 50 mM
(n¼153). Different superscripts between treatments, within a time
point, are significantly different (P<0.05).
Fig. 2. Effect of nuclear microinjection of the phosphatase inhibitor
(a) okadaic acid (OA) and (b) anti-PP1 antibodies (Anti-PP1) on mouse
oocyte germinal vesicle breakdown (GVBD) in the presence of the
specific MPF inhibitor, roscovitine. n¼number of oocytes assessed in
each treatment. Different superscripts between microinjection treat-
ments, within a time point, are significantly different (P< 0.01).
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absent. The presence of phosphorylated PP1 in GVBD
oocytes was confirmed through immunocytochemistry
and confocal image analysis (Fig. 5).
DISCUSSION
A large majority of mouse oocytes spontaneously
resume meiosis when removed from their follicular
environment, making it difficult to detect treatment-
enhanced rates of GVBD. Therefore, when assessing
factors that stimulate GVBD, it is helpful to control the
event by chemical inhibition. ThroughROSC treatment,
it was possible to modulate the number of oocytes
undergoing GVBD, without completely or irreversibly
inhibiting the system.ByusingROSCat adose of 50 mM,
mouse oocyte GVBD was held at intermediate levels,
which allowed formanipulation of the system, aswell as
detection of increased oocyte GVBD due to chemical
manipulation. It is important to realize that mechan-
isms of ROSC inhibition, and possible interaction with
PP’s, were not the focus of these experiments. This
ROSC treatment was designed as a model system, or a
means to an end, in attempting to elucidate which PP,
PP1, or PP2A is involved in regulating the event of
GVBD during meiosis.
Inhibition of GVBD by ROSC was successfully over-
come throughGVmicroinjection of bothOA and neutra-
lizing PP1 antibodies, but not anti-PP2A antibodies.
This suggests that PP1 may be the antagonistic phos-
phatase toMPF’s cdc2 kinase, responsible for regulating
the phosphorylated state of nuclear lamins and main-
tenance of NE integrity. Microinjection or culture of
oocytes inOA can overcomemeiotic inhibition caused by
chemical treatments suchascycloheximide (Gavinetal.,
1991), 6-DMAP and IBMX (Kalous et al., 1993). These
meiotic inhibitors are believed to interfere with meiotic
resumption upstream of MPF through inhibition of
protein synthesis (cyclin B) or alteration of cAMP levels.
These upstream interruptionsmayhave effects on other
regulators of oocyte meiotic progression, thus making
it difficult to draw any conclusions on interactions of
MPFandprotein phosphatases.Our results indicateGV
microinjection of OA can also overcome meiotic inhibi-
tion by ROSC. Roscovitine inhibits meiotic resumption
directly through MPF’s p34cdc2 kinase by occupying the
ATP binding site of cdc2kinase (Mermillod et al., 2000).
Through antibody neutralization of oocyte nuclear PP1,
under specific inactivation of MPF, our data suggests
PP1 is the OA-sensitive PP responsible for maintaining
NE integrity. With this said, it is not implied that
protein kinases do not also play an important regulatory
role in maintenance of NE integrity. We would suggest
that both MPF and PP1 are important in regulating
the phosphorylated state of nuclear phosphoproteins,
like lamins, that ultimately influence NE integrity.
This theory is further supported by studies showing
MPF subunits, cdc2kinase and cyclin B, predominately
localized in mouse (Mitra and Schultz, 1996) and
starfish (Ookata et al., 1992) oocyte nuclei. Maturation
promoting factor moves into nuclei of mouse oocytes in
conjunction with acquisition of meiotic competence
(Mitra and Schultz, 1996). In starfish oocytes, MPF
traffics to the nucleus prior to resumption of meiosis
(Ookata et al., 1992). PP-1 also translocates from the
cytoplasm to the nucleus in conjunctionwith acquisition
of meiotic competence (Smith et al., 1998a). In addition,
immunolocalization studies show PP1 translocates to
the nucleus of mitotic cells during the G2 phase
(Fernandez et al., 1992) prior to the mitotic G2/M phase
transition. Thus, both MPF and PP1 are present in
Fig. 3. Effect of nuclear microinjection of (a) OA, (b) anti-PP1, (c)
inhibitor I2, and (d) anti-PP2A antibodies (Anti-PP2A) on GVBD of
mouse oocytes cultured in the presence of the specific MPF inhibitor,
roscovitine. Graph displays percent GVBD greater than control
(vehicle injected). * Represent significant differences between treat-
ments and vehicle injected, within a time point (P< 0.01).
Fig. 4. Representative immunoblot of protein phosphatase-1 (PP1)
and phosphorylated PP1 (Phospho-Thr320-PP1) in mouse oocytes
at various stages of meiotic maturation. Lane 1: germinal vesicle-
intact (GV-intact, time of collection) oocytes, lane 2: oocytes that
underwent germinal vesicle breakdown (GVBD; 2 hr post-collection),
lane 3: oocytes developed tometaphase I (MI; 7 hr post-collection), and
lane 4: oocytes developed to metaphase II (MII; 16 hr post-collection).
Total protein from oocytes was loaded into each lane. The blot was
incubated with a polyclonal anti-PP1 antibody to show unphospory-
lated, oractivePP1 (toppanel). Inadditionblotswere incubatedwitha
polyclonal anti-Phospho-Thr320-PP1 antibody to show inactive PP1
(bottom panel). This experiment was performed in duplicate.
100 J.E. SWAIN ET AL.
thenucleus at a timewhen they can regulate phosphory-
lation of nuclear phosphoproteins important for main-
taining NE integrity or stimulating NE dissolution and
GVBD.
In somatic cells, trafficking of PP1 to the NE is
required for assembly of nuclear lamins (Steen et al.,
2000). PP-1 anchoring protein(s) exist within the as-
sembling mitotic NE and are requisite for NE re-
assembly (Steen et al., 2000). Specific inhibition of PP1
in mitotic cells demonstrates that this OA-sensitive PP
is themajor serine/threonine PP responsible for dephos-
phorylation of lamin-B, a process necessary for NE
re-assembly and maintenance of NE integrity (Thomp-
son et al., 1997). Dephosphorylation of lamin-B by
purified PP1 allows re-assembly of lamina polymers
(Peter et al., 1991). It has also been shown that
p34cdc2kinase acts directly on lamin-B receptors to cause
hyperphosphorylation inmitotic cells (Nikolakaki et al.,
1997) and evidence exists to suggest MPF is involved in
NE disassembly in clam oocytes (Dessev et al., 1991).
These findings suggest that PP1 and MPF likely
regulate phosphorylation of NE-associated proteins
and dictate the integrity of the NE during mitosis and
meiosis.
Monkey oocytes transiently exposed to low concentra-
tions of OA have increased rates of MII development
compared to control treatments (Smith et al., 1998b),
primarily due to enhanced meiotic initiation. However,
prolonged exposure of oocytes to OA results in severe
cytoplasmic aberrations (Smith et al., 1998b) andmicro-
tubule abnormalities (Alexander et al., 1991). These
observations, coupled with those indicating PP2A is
associated with cytoskeletal elements such as micro-
tubules, centromeres, and spindles (Van Dolah and
Ramsdell, 1992; Sontag et al., 1995; Tournebize et al.,
1997; Lu et al., 2002) suggests PP2A involvement with
microtubule polymerization, chromatin segregation,
and completion of meiosis. Oocytes injected with anti-
PP1 antibodies showed higher rates ofMII development
compared to OA injected even though they had compar-
able GVBD rates. This is likely due to inhibitory effects
of OA exposure on PP2A and compromised meiotic
progression beyond GVBD, further supporting the idea
that prolonged inhibition of PP2A may prevent oocytes
from completingmeiosis.Nuclearmicroinjection of anti-
PP2A had no effect on MII development in our study.
From these studies, it is unclear if nuclear anti-PP2A
microinjection was capable of neutralizing the cytoplas-
mic PP2A following GVBD. Currently, experiments
are being performed addressing the issue of antibody
neutralization of PP2A followingGVBDand subsequent
microtubule polymerization, chromatin segregation,
and normal development to MII.
Previous reports have shown that nanomolar concen-
trations of I2 completely abolish PP1 activity (Huang
and Glinsmann, 1976; Thompson et al., 1997; Huang
et al., 1999). It has been shown that I2 is present in
oocytes of starfish (Pondaven and Cohen, 1987) and
Xenopus (Foulkes andMaller, 1982). Research in our lab
has also verified the presence of I2 mRNA and protein
in mouse oocytes. Microinjection of I2 into nuclei of
ROSC-arrested oocytes had no effect on GVBD. I2 is a
cytoplasmic regulator of PP1 and, therefore, may not
convey activity when microinjected into nuclei. This
may be the result of blockage of PP1/I2 interactive sites
by PP1 binding to nuclear tethering proteins or
substrates. It is known that I2 binds to multiple sites
on PP1 catalytic subunit (Yang et al., 2000) and only
some of these interactions mediate PP1 inhibition
(Connor et al., 2000). Alternatively, the dosage of I2
usedmaynothavebeensufficient to inhibitPP1activity.
Yet this alternative is unlikely since similar doses of I2
have been demonstrated to inhibit cytoplasmic PP1
activity in numerous somatic cell systems (Thompson
et al., 1997; Huang et al., 1999). A nuclear inhibitor of
PP1, NIPP1, has been detected in rat liver nuclei
(Jagiello et al., 1995) and bovine thymus (Buellens
et al., 1992).However, studies in our lab failed to identify
this enzyme in fully-grown mouse GV-intact oocytes.
Lack of this nuclear regulator of PP1 activity in mouse
oocyte nuclei raises the question of how nuclear PP1 is
regulated in mouse oocytes.
Based on results of previous experiments, purified
recombinant PP1 was also injected into oocyte GV,
without inhibition of p34cdc2kinase activity, to deter-
mine whether NE integrity could be maintained. Micro-
injection of activePP1 in an anaphasemitotic cell affects
subsequent cell cycle activity, resulting in accelerated
Fig. 5. Representative confocal immunofluorescent micrograph displaying localization of PP1,
Phospho-Thr320-PP1, and chromatin in GV-intact and oocyte that have undergone GVBD. The left
panel shows presence of PP1 (green) in GV-intact oocytes, while the center panel shows chromatin,
stained in red, and lack of phosphorylated PP1 (no green). The right panel shows presence of Phospho-
Thr320-PP1 (green) in association with chromatin (red) in oocytes that have undergone GVBD.
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cytokinesis and reflattening of the injected cell (Fer-
nandez et al., 1992). Failure of PP1GV-microinjection to
effect subsequent meiotic progression by preventing
GVBD in our study may be due to the subsequent
phosphorylated state of endogenous and injected PP1.
In mitotic cells, MPF’s cdc2 kinase phosphorylates PP1
on Thr 320, resulting in its inactivation (Dohadwala
et al., 1994; Kwon et al., 1997). Interestingly, both PP1
andMPFmove into the oocyte nucleus around the same
time during meiosis (Mitra and Schultz, 1996; Smith
et al., 1998a). Using Western blot analysis and confocal
imaging, we found the phosphoryated state, and there-
fore the activity of PP1, changes during oocyte matura-
tion. Due to the regulatory role ofMPF onPP1 inmitotic
cells, it is reasonable to assume the activity of MPFmay
have already reached levels sufficient enough to phos-
phorylate and, therefore, inhibit injected PP1 in the
oocyte. Alternatively, amounts of PP1 injected may not
have been adequate to elicit an effect. However, this is
not likely, as previous studies have shown an effect of
PP1 on mitotic cell cycle activity at concentrations far
lower than those used in this study (Fernandez et al.,
1992). In the future, it will be important to determine
the developmental timing of PP1 phosphorylation and
whether this phosphorylation occurs during in vivo
meiotic maturation.
CONCLUSIONS
In conclusion, we report here that inhibition of oocyte
nuclear PP1, through specific antibody neutralization,
can overcomeROSC induced block of GVBDandmeiotic
resumption. This provides the first direct evidence that
nuclear PP1 is involved in regulation of oocyte nuclear
membrane integrity. Utilizing Western blot analysis
and confocal immunocytochemistry, we also demon-
strate phosphorylation of PP1 at Thr320, and therefore
inactivation of PP1 at or around the time of GVBD.
These results reveal a cell-cycle dependent regulatory
role of PP1 in nuclear envelope dynamics and oocyte
meiotic progression.
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